Study links aspirin with lower melanoma risk

03/12/2013 | SkinAndAllergyNews.com

Postmenopausal women who take aspirin regularly might have a lower risk of melanoma, researchers analyzing data from the Women's Health Initiative report in the journal Cancer. The protective effect appeared to grow stronger with increased duration, and a similar association was not seen with other NSAIDs. The findings were consistent with studies of aspirin and other cancers, including colorectal malignancies, dermatologist Jean Tang and fellow researchers said.

View Full Article in:

SkinAndAllergyNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC